| Dr Robert Philip Wise, MD, MPH | |
|
1612 Auburn Ave, Rockville, MD 20850-1144 | |
| (301) 424-2908 | |
| Not Available |
| Full Name | Dr Robert Philip Wise |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Public Health & General Preventive Medicine |
| Location | 1612 Auburn Ave, Rockville, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518081488 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083P0901X | Preventive Medicine - Public Health & General Preventive Medicine | 39942 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Philip Wise, MD, MPH 1612 Auburn Ave, Rockville, MD 20850-1144 Ph: (301) 424-2908 | Dr Robert Philip Wise, MD, MPH 1612 Auburn Ave, Rockville, MD 20850-1144 Ph: (301) 424-2908 |
News Archive
Recent recommendations by the Institute of Medicine (IOM) call for women who are overweight or obese to gain more weight than they should, a Saint Louis University obstetrician wrote in a January commentary for Obstetrics & Gynecology.
Since the recession began the number of smokers quitting has fallen according to new research being presented at the NCRI Cancer Conference in Liverpool today.
Nuron Biotech Inc., a specialty biologics and vaccines company, today announced it has acquired from Pfizer Inc. Meningitec, which is a vaccine for the prevention of invasive disease caused by Neisseria meningitidis serogroup C.
Merck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved JUVISYNC(sitagliptin and simvastatin), a new treatment for type 2 diabetes that combines the glucose-lowering medication sitagliptin, the active component of JANUVIA (sitagliptin), with the cholesterol-lowering medication ZOCOR.
Western States Biopharmaceuticals, Inc., a privately-held biotechnology company focusing on the development of novel therapies to treat inflammatory disease, and the University of Colorado announced today that they have entered into a licensing agreement for approaches to inhibiting newly discovered T cell Cytokine Inducing Surface Molecules, or TCISM autoimmune disease drug discovery targets.
› Verified 8 days ago
Dr. Ling Chin, MD, MPH Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 12820 Circle Dr, Rockville, MD 20850 Phone: 240-406-7478 | |
Dr. Lisa A Pearse, MD, MPH Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 1413 Research Blvd, Bldg 102, Rockville, MD 20850 Phone: 301-319-0000 | |
Dr. Paul Jung, MD, MPH, FACPM Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 5600 Fishers Ln, Rockville, MD 20857 Phone: 301-945-3358 | |
Dr. Mark Schiffman, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 6120 Executive Boulevard, Room 7012, Rockville, MD 20852 Phone: 301-451-4562 | |
Charles Lucey, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 10201 Grosvenor Pl, 1102, Rockville, MD 20852 Phone: 301-827-4333 | |
Dr. Jennifer Miller Croswell, MD, MPH Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 540 Gaither Rd, Room 6111, Rockville, MD 20850 Phone: 301-427-1638 | |
Dr. David Gan, M.D., DR.PH Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 14316 Travilah Rd, Rockville, MD 20850 Phone: 301-529-6821 |